Epimède Overview

  • Investor Type
  • Venture Capital
  • Status
  • Active
  • Professionals
  • 3
Professionals
  • Investments
  • 12
  • Portfolio
  • 6
  • Exits
  • 3
Exits

Epimède General Information

Description

Epimède is a venture capital firm based in Liège, Belgium. With an investment focus on life sciences (biology, biotechnology, MedTech, etc), engineering services (NTIC and Cleantech) and corporate services, the firm typically invests between €1 million to €7 million in companies which have their head offices or main operational offices in Wallonia for an investment tenure of about 3 to 5 years.

Contact Information

Website
www.epimede.com
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Other Investor Types
Growth/Expansion
Primary Office
  • Rue Lambert-Lombard 3 à
  • 4000 Liège
  • Belgium
+32 04 000 00 00

Epimède Investments (12)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
ImCyse 03-Feb-2021 Later Stage VC 000.00 Drug Discovery Clinical Trials - Phase 2
0000 00000 0000000 19-Jan-2021 00000 00000 00.00 Surgical Devices Generating Revenue 00000000 000000
0000000 15-Jul-2019 00000 00000 00.000 Discovery Tools (Healthcare) Generating Revenue
000000 18-Jun-2019 00000 00000 000.00 Drug Discovery Clinical Trials - Phase 2 0000 000000
0000 00000 0000000 18-Oct-2018 00000 00000 00.000 Surgical Devices Generating Revenue 00000000 000000
000000000 (0000000 01-Feb-2018 00000 00000 00.000 Decision/Risk Analysis Generating Revenue 0000000 000000000 00.0
0000000 17-Nov-2017 00000 00000 000.00 Discovery Tools (Healthcare) Generating Revenue 0000 0000000
00000000 (00000000 15-Mar-2017 00000 00000 00.000 Biotechnology Generating Revenue
Diagenode 20-Jun-2016 Later Stage VC 00.000 Biotechnology Generating Revenue 0000 0000000
Novadip 10-Sep-2015 Early Stage VC 000.00 Biotechnology Generating Revenue
You’re viewing 10 of 12 investments. Get the full list »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Epimède Exits (3)

Company Name Exit Date Exit Type Exit Size
Diagenode 01-Mar-2021 Merger/Acquisition 00000
0000 00000 0000000 30-May-2017 000000000000000000
00000 000000000000000000
To view Epimède’s complete exits history, request access »

Epimède Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Epimède Team (3)

Name Title Deals Funds Boards Office
Philippe Degeer Co-Founder & Investment Manager 0 Liège, Belgium
Marc Foidart Founder & Chief Investment Officer 00 0 0 Liège, Belgium
Bernard Surlemont Ph.D Executive, Management Team 0 0 Liège, Belgium
To view Epimède’s complete team members history, request access »